Cutaneous Melanoma — Trials

Cutaneous Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

241 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 78
Recruiting: 39
Ph III recruiting: 3
Growth YoY: —
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.1%
Trials / 1,000 deaths: 9.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (42)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06299878	MelPRO-0322 (CRISTINA Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns](CRISTINA)	unknown	—	72	Russian Academy of Medical SciencesOTHER	1	Mar 8, 2024	clinicaltrials
NCT02437279	Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients(OpACIN)	unknown	Phase 1	20	The Netherlands Cancer InstituteOTHER